Can the DSM-5 framework enhance the diagnosis of MCI?

Neurology

Volumn 81, Issue 23, 2013, Pages 2045-2050

  Ganguli, Mary ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; AMBIGUITY; AMNESIA; BEHAVIOR; CEREBROVASCULAR DISEASE; COGNITION; DAILY LIFE ACTIVITY; DELIRIUM; DEPRESSION; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DSM-5; FAMILY HISTORY; FUNCTIONAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTOXICATION; MENTAL DETERIORATION; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; NATIONAL HEALTH ORGANIZATION; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SELF CONCEPT; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE; TEST RETEST RELIABILITY; TRAUMATIC BRAIN INJURY;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MILD COGNITIVE IMPAIRMENT;

EID: 84892402609     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000436944.01023.e5     Document Type: Review

References (24)

1. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308
2. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment: beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246
3. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194
4. American Psychiatric Association. DSM-5: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013
5. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC: American Psychiatric Association; 1987
6. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349:1793-1796
7. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging- Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7: 270-279
8. Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012;27:349-356
9. Rabins PV, Lyketos CG. A commentary on the proposed DSM revision regarding the classification of cognitive disorders. Am J Geriatr Psychiatry 2011;19:201-204
10. Institute of Medicine of the National Academies, Board on Population Health and Public Health Practice. Neurocognitive outcomes. In: Gulf War and Health: Volume 7: Long-Term Consequences of Traumatic Brain Injury. Washington, DC: The National Academies Press; 2008: 173-196
11. Dubois B, Feldman HH, Jacova CC, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007:6: 734-746
12. Schneider JA, Arvanitakis Z, Leurgens SE, Bennett DA. The neuropathology of probable Alzheimer's disease and mild cognitive impairment. Ann Neurol 2009;66: 200-208
13. Allegri RF, Glaser FB, Taragano FE, Buschke H. Mild cognitive impairment: believe it or not? Int Rev Psychiatry 2008;20:357-363
14. Hughes TF, Snitz BE, Ganguli M. Should mild cognitive impairment be subtyped? Curr Opin Psychiatry 2011;24: 237-242
15. Alzheimer's Disease Neuroimaging Initiative Grand Opportunity (ADNI-GO) Protocol Synopsis, 2010. Available at: http://www.adni-info.org/Scientists/Pdfs/ ADNI-GO-Protocol.pdf. c, 2013
16. Duara R, Loewenstein DA, Greig MT, et al. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates. Am J Geriatr Psychiatry 2011;19: 951-960
17. Peters ME, Rosenberg PB, Steinberg M, et al. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. Am J Geriatr Psychiatry Epub 2012 Sep 12
18. American Psychiatric Association. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 2000
19. Biomarkers Definition Working Group, NIH Director's Initiative. Biomarkers and surrogate endpoints: preferred definitions and conceptual endpoints. Clin Pharmacol Ther 2001;69:89-95
20. Jedynak BM, Lang A, Liu B, et al. A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease Neuroimaging Initiative Cohort. Neuroimage 2012;63:1478-1486
21. Jack CR, Albert M, Knopman D, et al. Introduction to revised criteria for the diagnosis of Alzheimer's disease: National Institute on Aging and the Alzheimer Association workgroups. Alzheimers Dement 2011;7:257-262
22. Brainerd CJ, Reyna VF, Petersen RC, et al. Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study. Neuropsychology 2011;25:679-689
23. Khachaturian AS, Corcoran CD, Mayer LS, et al. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache County Study. Arch Gen Psychiatry 2004;61:518-524
24. World Health Organization. International classification of functioning, disability, and health (ICF), 2001. Available at: http://www.who.int/ classifications/icf/en/. Accessed June 24, 2010